Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ORMP

Oramed Pharmaceuticals (ORMP)

Oramed Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ORMP
DateTimeSourceHeadlineSymbolCompany
05/05/201523:25PR Newswire (US)Oramed to Present at Upcoming ConferencesNASDAQ:ORMPOramed Pharmaceuticals Inc
01/05/201507:33Analyst Ratings NetworkOramed Pharmaceuticals Rating Reiterated by Zacks (ORMP)NASDAQ:ORMPOramed Pharmaceuticals Inc
29/04/201505:15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
28/04/201523:25PR Newswire (US)Oramed Pharmaceuticals Inc. Issues Phase IIb Study Update LetterNASDAQ:ORMPOramed Pharmaceuticals Inc
20/04/201522:15PR Newswire (US)Oramed to Present at the GTC Diabetes SummitNASDAQ:ORMPOramed Pharmaceuticals Inc
03/04/201523:04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ORMPOramed Pharmaceuticals Inc
03/04/201523:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ORMPOramed Pharmaceuticals Inc
02/04/201501:06PR Newswire (US)Oramed Enrolls First Patient in its Glucose Clamp Study for Oral InsulinNASDAQ:ORMPOramed Pharmaceuticals Inc
02/04/201501:06PR Newswire (US)Oramed Enrolls First Patient in its Glucose Clamp Study for Oral InsulinNASDAQ:ORMPOramed Pharmaceuticals Inc
21/03/201500:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
05/03/201500:15PR Newswire (US)Oramed to Present at the ROTH ConferenceNASDAQ:ORMPOramed Pharmaceuticals Inc
05/03/201500:15PR Newswire (US)Oramed to Present at the ROTH ConferenceNASDAQ:ORMPOramed Pharmaceuticals Inc
26/02/201509:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
26/02/201509:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
26/02/201509:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
20/02/201500:15PR Newswire (US)Oramed to Present Poster at the GTC Protease Inhibitors in Drug Discovery ConferenceNASDAQ:ORMPOramed Pharmaceuticals Inc
20/02/201500:15PR Newswire (US)Oramed to Present Poster at the GTC Protease Inhibitors in Drug Discovery ConferenceNASDAQ:ORMPOramed Pharmaceuticals Inc
14/02/201508:59Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ORMPOramed Pharmaceuticals Inc
06/02/201500:25PR Newswire (US)Oramed to Present at the BIO CEO & Investor ConferenceNASDAQ:ORMPOramed Pharmaceuticals Inc
06/02/201500:25PR Newswire (US)Oramed to Present at the BIO CEO & Investor ConferenceNASDAQ:ORMPOramed Pharmaceuticals Inc
29/01/201505:47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
29/01/201501:00PR Newswire (US)Oramed Pharmaceuticals Inc. Issues Letter to ShareholdersNASDAQ:ORMPOramed Pharmaceuticals Inc
29/01/201501:00PR Newswire (US)Oramed Pharmaceuticals Inc. Issues Letter to ShareholdersNASDAQ:ORMPOramed Pharmaceuticals Inc
17/01/201500:25PR Newswire (US)Oramed Granted Patent in Israel for Oral Administration of GLP-1NASDAQ:ORMPOramed Pharmaceuticals Inc
17/01/201500:25PR Newswire (US)Oramed Granted Patent in Israel for Oral Administration of GLP-1NASDAQ:ORMPOramed Pharmaceuticals Inc
10/01/201503:36Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ORMPOramed Pharmaceuticals Inc
09/01/201507:27Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ORMPOramed Pharmaceuticals Inc
16/12/201401:42Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ORMPOramed Pharmaceuticals Inc
10/12/201402:30Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ORMPOramed Pharmaceuticals Inc
04/12/201400:25PR Newswire (US)Oramed Closes $5 Million Investment From Guangxi Wuzhou Pharmaceutical CompanyNASDAQ:ORMPOramed Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ORMP